These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 27959931)

  • 41. Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics.
    Wagner DJ; Hu T; Wang J
    Pharmacol Res; 2016 Sep; 111():237-246. PubMed ID: 27317943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacogenetic variation and metformin response.
    Chen S; Zhou J; Xi M; Jia Y; Wong Y; Zhao J; Ding L; Zhang J; Wen A
    Curr Drug Metab; 2013 Dec; 14(10):1070-82. PubMed ID: 24329113
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney.
    Motohashi H; Inui K
    AAPS J; 2013 Apr; 15(2):581-8. PubMed ID: 23435786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitro.
    Breining P; Jensen JB; Sundelin EI; Gormsen LC; Jakobsen S; Busk M; Rolighed L; Bross P; Fernandez-Guerra P; Markussen LK; Rasmussen NE; Hansen JB; Pedersen SB; Richelsen B; Jessen N
    Diabetes Obes Metab; 2018 Sep; 20(9):2264-2273. PubMed ID: 29752759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.
    Nies AT; Koepsell H; Damme K; Schwab M
    Handb Exp Pharmacol; 2011; (201):105-67. PubMed ID: 21103969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of Experimental Conditions on the Evaluation of Interactions between Multidrug and Toxin Extrusion Proteins and Candidate Drugs.
    Lechner C; Ishiguro N; Fukuhara A; Shimizu H; Ohtsu N; Takatani M; Nishiyama K; Washio I; Yamamura N; Kusuhara H
    Drug Metab Dispos; 2016 Aug; 44(8):1381-9. PubMed ID: 27271370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metformin targets ovarian cancer stem cells in vitro and in vivo.
    Shank JJ; Yang K; Ghannam J; Cabrera L; Johnston CJ; Reynolds RK; Buckanovich RJ
    Gynecol Oncol; 2012 Nov; 127(2):390-7. PubMed ID: 22864111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [11C]-Labeled Metformin Distribution in the Liver and Small Intestine Using Dynamic Positron Emission Tomography in Mice Demonstrates Tissue-Specific Transporter Dependency.
    Jensen JB; Sundelin EI; Jakobsen S; Gormsen LC; Munk OL; Frøkiær J; Jessen N
    Diabetes; 2016 Jun; 65(6):1724-30. PubMed ID: 26993065
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin.
    Shikata E; Yamamoto R; Takane H; Shigemasa C; Ikeda T; Otsubo K; Ieiri I
    J Hum Genet; 2007; 52(2):117-122. PubMed ID: 17111267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis.
    Dujic T; Zhou K; Yee SW; van Leeuwen N; de Keyser CE; Javorský M; Goswami S; Zaharenko L; Hougaard Christensen MM; Out M; Tavendale R; Kubo M; Hedderson MM; van der Heijden AA; Klimčáková L; Pirags V; Kooy A; Brøsen K; Klovins J; Semiz S; Tkáč I; Stricker BH; Palmer C; 't Hart LM; Giacomini KM; Pearson ER
    Clin Pharmacol Ther; 2017 Jun; 101(6):763-772. PubMed ID: 27859023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin.
    Chen L; Pawlikowski B; Schlessinger A; More SS; Stryke D; Johns SJ; Portman MA; Chen E; Ferrin TE; Sali A; Giacomini KM
    Pharmacogenet Genomics; 2010 Nov; 20(11):687-99. PubMed ID: 20859243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Organic cation transporter and multidrug and toxin extrusion 1 co-mediated interaction between metformin and berberine.
    Shi R; Xu Z; Xu X; Jin J; Zhao Y; Wang T; Li Y; Ma Y
    Eur J Pharm Sci; 2019 Jan; 127():282-290. PubMed ID: 30428337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transfer of metformin across the rat placenta is mediated by organic cation transporter 3 (OCT3/SLC22A3) and multidrug and toxin extrusion 1 (MATE1/SLC47A1) protein.
    Ahmadimoghaddam D; Staud F
    Reprod Toxicol; 2013 Aug; 39():17-22. PubMed ID: 23562376
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Multiplexed HILIC-MS/HRMS Assay for the Assessment of Transporter Inhibition Biomarkers in Phase I Clinical Trials: Isobutyryl-Carnitine as an Organic Cation Transporter (OCT1) Biomarker.
    Luo L; Ramanathan R; Horlbogen L; Mathialagan S; Costales C; Vourvahis M; Holliman CL; Rodrigues AD
    Anal Chem; 2020 Jul; 92(14):9745-9754. PubMed ID: 32551505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different effect of testosterone and oestrogen on urinary excretion of metformin via regulating OCTs and MATEs expression in the kidney of mice.
    He R; Ai L; Zhang D; Wan L; Zheng T; Yin J; Lu H; Lu J; Lu F; Liu F; Jia W
    J Cell Mol Med; 2016 Dec; 20(12):2309-2317. PubMed ID: 27469532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sulfenamide derivatives can improve transporter-mediated cellular uptake of metformin and induce cytotoxicity in human breast adenocarcinoma cell lines.
    Markowicz-Piasecka M; Huttunen J; Sikora J; Huttunen KM
    Bioorg Chem; 2019 Jun; 87():321-334. PubMed ID: 30913467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients.
    Toyama K; Yonezawa A; Tsuda M; Masuda S; Yano I; Terada T; Osawa R; Katsura T; Hosokawa M; Fujimoto S; Inagaki N; Inui K
    Pharmacogenet Genomics; 2010 Feb; 20(2):135-8. PubMed ID: 20016398
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells.
    Tsuda M; Terada T; Ueba M; Sato T; Masuda S; Katsura T; Inui K
    J Pharmacol Exp Ther; 2009 Apr; 329(1):185-91. PubMed ID: 19164462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. No Effect of Plazomicin on the Pharmacokinetics of Metformin in Healthy Subjects.
    Choi T; Komirenko AS; Riddle V; Kim A; Dhuria SV
    Clin Pharmacol Drug Dev; 2019 Aug; 8(6):818-826. PubMed ID: 30605260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis.
    Griss T; Vincent EE; Egnatchik R; Chen J; Ma EH; Faubert B; Viollet B; DeBerardinis RJ; Jones RG
    PLoS Biol; 2015 Dec; 13(12):e1002309. PubMed ID: 26625127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.